|Articles|August 1, 2017
- Pharmaceutical Executive-08-01-2017
- Volume 37
- Issue 8
Pharmaceutical Executive, August 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive August 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 8 years ago
Health Policy Problem Solver: Fumie Griegoover 8 years ago
Dealmaking in 2017: Striking a Balanceover 8 years ago
Beyond the Science: Commercial Implications From ASCO 2017over 8 years ago
News Spotlight: Pharmaover 8 years ago
Pharma’s Marijuana Makeoverover 8 years ago
The 'Hear' and Now for Pharma and Social Mediaover 8 years ago
Pressure Mounts on FDA, Pharma to Tackle Opioid Abuseover 8 years ago
Syncing Social Media With Value-Care Modelover 8 years ago
AI-based Social Listening as Aid to Pharmacovigilanceover 8 years ago
Country Report: IndonesiaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Public Citizen Files Suit Against Trump Administration for Undisclosed Details of Pfizer and Eli Lilly Drug-Pricing Deals: Report
2
FDA Approves Yuvezzi to Treat Presbyopia in Adults
3
AstraZeneca Enters $4.7 Billion Collaboration Agreement with CSPC Pharmaceuticals
4
Bringing Huntington’s Story to the Public: Q&A with Heather DeMyers
5